Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Xeris Biopharma Holdings Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Xeris Biopharma Holdings Inc. June 7, 202389.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Larimar Therapeutics Inc. | Open-market purchase | +5,000 | $5.00 | $25,000 |
| Aug 28, 2025 | Xeris Biopharma Holdings Inc. | Option exercise | +47,040 | $6.66 | $313,286 |
| Aug 28, 2025 | Xeris Biopharma Holdings Inc. | Open-market sale | −42,232 | $7.92 | $334,477 |
| Jun 4, 2025 | Xeris Biopharma Holdings Inc. | Grant or award | +50,000 | — | — |
| Jun 5, 2024 | Xeris Biopharma Holdings Inc. | Grant or award | +50,000 | — | — |
| Mar 15, 2024 | Xeris Biopharma Holdings Inc. | Other | +6,502 | — | — |
| Nov 27, 2023 | Xeris Biopharma Holdings Inc. | Open-market purchase | +5,400 | $1.87 | $10,098 |
| Jun 7, 2023 | Xeris Biopharma Holdings Inc. | Grant or award | +42,500 | — | — |
Questions about Jeffrey W. Sherman
What boards is Jeffrey W. Sherman on?
Jeffrey W. Sherman sits on the boards of Larimar Therapeutics Inc. and Xeris Biopharma Holdings Inc.
How long has Jeffrey W. Sherman served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.